rebif 8.8micrograms0.2ml (2.4million units) solution for injection pre-filled syringes
2.4million units - interferon beta-1a - solution for injection - 12mega u/1ml
rebif 22micrograms0.5ml (6million units) solution for injection pre-filled pen
6million units - interferon beta-1a - solution for injection - 12mega u/1ml
rebif 44micrograms0.5ml (12million units) solution for injection pre-filled pen
12million units - interferon beta-1a - solution for injection - 24mega u/1ml
rebif 8.8micrograms0.2ml (2.4million units) solution for injection pre-filled pen
2.4million units - interferon beta-1a - solution for injection - 12mega u/1ml
plegridy 63micrograms0.5ml solution for injection pre-filled pen
biogen idec ltd - peginterferon beta-1a - solution for injection - 126microgram/1ml
plegridy 94micrograms0.5ml solution for injection pre-filled pen
biogen idec ltd - peginterferon beta-1a - solution for injection - 188microgram/1ml
avonex solution for injection 30 mcg/0.5ml
مستودع أدوية أداتكو - adatco drug store - interferon beta-1a 30 mcg/0.5ml - 30 mcg/0.5ml
rebif
pharmacy retailing (nz) ltd t/a healthcare logistics - interferon beta-1a 44 µg/ml (6miu per 0.5ml dose); - solution for injection - 22 mcg/0.5ml - active: interferon beta-1a 44 µg/ml (6miu per 0.5ml dose) excipient: acetic acid benzyl alcohol mannitol methionine poloxamer sodium hydroxide water for injection - o ambulatory patients with multiple sclerosis who have experienced two or more relapses within the last 2 years.
extavia
novartis europharm limited - interferon beta-1b - multiple sclerosis - immunostimulants, - extavia is indicated for the treatment of:patients with a single demyelinating event with an active inflammatory process, if it is severe enough to warrant treatment with intravenous corticosteroids, if alternative diagnoses have been excluded, and if they are determined to be at high risk of developing clinically definite multiple sclerosis;patients with relapsing-remitting multiple sclerosis and two or more relapses within the last two years;patients with secondary progressive multiple sclerosis with active disease, evidenced by relapses.
betaferon
bayer (pty) ltd - interferon beta - injection - each 3 ml solution contains interferon beta 0,3 mg